We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
PUT
Bankunited
BKU
$3.24B
| $63K | ﹤0.01% |
1,300
+700
| +117% | +$32.9K |
|
2952
CALL
Peloton Interactive
PTON
$2.21B
| $62.6K | ﹤0.01% |
10,600
| – | – |
|
2953
CAMP4 Therapeutics
CAMP
$276M
| $62K | ﹤0.01% |
+14,191
| New | +$61.2K |
|
2954
Lucid Diagnostics
LUCD
$171M
| $61.9K | ﹤0.01% |
+57,893
| New | +$62.4K |
|
2955
AudioEye
AEYE
$100M
| $60.1K | ﹤0.01% |
10,350
-13,467
| -57% | -$93.7K |
|
2956
TROOPS Inc
TROO
$257M
| $58.8K | ﹤0.01% |
+23,900
| New | +$75.4K |
|
2957
LivePerson
LPSN
| $58K | ﹤0.01% |
30,550
-56,077
| -65% | -$135K |
|
2958
Sportsman's Warehouse
SPWH
$49.7M
| $57.8K | ﹤0.01% |
43,482
-228,080
| -84% | -$312K |
|
|
NAGE
2959
Niagen Bioscience
NAGE
$245M
| $57.6K | ﹤0.01% |
+18,059
| New | +$73.3K |
|
|
MREO
2960
Mereo BioPharma
MREO
$40.7M
| $57.6K | ﹤0.01% |
179,884
-507,103
| -74% | -$152K |
|
2961
PUT
Alcoa
AA
$13.7B
| $57.4K | ﹤0.01% |
1,100
-700
| -39% | -$46.9K |
|
|
PSIG
2962
PS International Group
PSIG
$27.8M
| $56K | ﹤0.01% |
+44,075
| New | +$334K |
|
2963
PodcastOne
PODC
$78.4M
| $55.7K | ﹤0.01% |
+12,460
| New | +$44.6K |
|
2964
CALL
PepsiCo
PEP
$189B
| $54.2K | ﹤0.01% |
+400
| New | +$59.8K |
|
2965
CALL
DexCom
DXCM
$31.9B
| $53.9K | ﹤0.01% |
800
-900
| -53% | -$60K |
|
|
2966
PUT
DexCom
DXCM
$31.9B
| $53.9K | ﹤0.01% |
800
-1,300
| -62% | -$86.6K |
|
2967
CALL
Mondelez International
MDLZ
$78.7B
| $52.1K | ﹤0.01% |
900
| – | – |
|
2968
PUT
Mastercard
MA
$500B
| $51.4K | ﹤0.01% |
+100
| New | +$49.9K |
|
|
HIMX
2969
PUT
Himax Technologies
HIMX
$2.46B
| $50.6K | ﹤0.01% |
+3,300
| New | +$51.2K |
|
2970
Lantern Pharma
LTRN
$23.5M
| $49.8K | ﹤0.01% |
+11,946
| New | +$35K |
|
2971
CALL
Spotify
SPOT
$109B
| $45.9K | ﹤0.01% |
+100
| New | +$47.7K |
|
2972
CALL
Lucid Motors
LCID
$1.82B
| $45.5K | ﹤0.01% |
6,800
-32,500
| -83% | -$210K |
|
2973
PUT
JFrog
FROG
$10.7B
| $45.4K | ﹤0.01% |
500
+400
| +400% | +$26K |
|
|
ESPR
2974
DELISTED
Esperion Therapeutics
ESPR
| $44.6K | ﹤0.01% |
14,118
-7,060,965
| -100% | -$19.8M |
|
2975
PUT
CF Industries
CF
$20.3B
| $43.3K | ﹤0.01% |
400
-8,800
| -96% | -$1.04M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.